BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Analyst Ratings

NASDAQ:BDRX • US59564R8806

1.09 USD
-0.12 (-9.92%)
At close: Feb 12, 2026
1.08 USD
-0.01 (-0.92%)
After Hours: 2/12/2026, 8:00:02 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to BDRX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 183.6. This target is 16744.04% above the current price.
  • BDRX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BDRX.
  • In the previous month the buy percentage consensus was at a similar level.
  • BDRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
BDRX Historical Analyst RatingsBDRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.09181.80183.60183.60189.00 - 16,578.90% 16,744.04% 16,744.04% 17,239.45%
BDRX Current Analyst RatingBDRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-02-08 Ladenburg Thalmann Initiate Buy

BIODEXA PHARMACEUTICALS-ADR / BDRX FAQ

Can you provide the average price target for BIODEXA PHARMACEUTICALS-ADR stock?

7 analysts have analysed BDRX and the average price target is 183.6 USD. This implies a price increase of 16744.04% is expected in the next year compared to the current price of 1.09.


What is the consensus rating for BIODEXA PHARMACEUTICALS-ADR (BDRX) stock?

The consensus rating for BIODEXA PHARMACEUTICALS-ADR (BDRX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover BIODEXA PHARMACEUTICALS-ADR (BDRX) stock?

The number of analysts covering BIODEXA PHARMACEUTICALS-ADR (BDRX) is 7.